Richard Mason, MD
Sports Medicine · Easton, MDNPI 1508862285
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (53.7%), food and beverage and education — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Supreme Orthopedic Systems, LLC at 42.0% of the total. 2025 is the largest year on record at $1,557, more than ten times the $84 reported in 2019.
Across 66 payments — averaging $89.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supreme Orthopedic Systems, LLC$2K
- Arthrex$2K
- Pacira Pharmaceuticals Incorporated$701
- Johnson & Johnson$336
- Smith+Nephew$283
- Medical Device Business Services, Inc.$137
- plus $104 from 4 others
What the payments were for
- Travel & lodging$3,17054%
- Food & beverage$1,39224%
- Education$1,33723%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supreme Orthopedic Systems, LLC | 10 | $2,475 |
| Arthrex | 28 | $1,864 |
| Pacira Pharmaceuticals Incorporated | 6 | $701 |
| Johnson & Johnson(2 entities) | 12 | $336 |
| Smith+Nephew | 4 | $283 |
| Medical Device Business Services, Inc. | 1 | $137 |
| KCI USA, Inc. | 1 | $32 |
| Baudax Bio Inc. | 2 | $32 |
| Vericel Corporation | 1 | $22 |
| Merck | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Iovera$617
- STRATAFIX$271
- DERMABOND PRINEO$134
- REAL INTELLIGENCE$126
- Journey II$126
- VISIONAIRE Solutions$114
- NAVIO$114
How this compares
$5,900 in reported general payments places this provider in the 70th percentile of 111 sports medicine providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 91 | $639 |
| Mupirocin | 96 | $626 |
| Meloxicam | 120 | $594 |
| Cyclobenzaprine Hcl | 68 | $454 |
| Gabapentin | 32 | $414 |
| Celecoxib | 13 | $184 |
| Amoxicillin | 80 | $112 |
| Tramadol Hcl | 35 | $108 |
| Prednisone | 22 | $98 |
| Oxycodone Hcl | 12 | $81 |
| Clindamycin Hcl | 15 | $24 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Easton
- Jason JancoskoEaston$20K
- Sheila TaylorEaston$3K
- Garrett LynchAnnapolis$1.4M
- Raymond ThalBethesda$779K
- Jason ScoppSalisbury$637K
- John ChristoforettiBethesda$418K
- Jonas RudzkiChevy Chase$386K
- Matthew LevineFrederick$364K
- Abdulaziz AhmedBaltimore$85K
- Taylor WileySalisbury$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.